Publications by authors named "David Morfitt"

Claim this Profile
2
2-Pyridyl P1'-substituted symmetry-based human immunodeficiency virus protease inhibitors (A-792611 and A-790742) with potential for convenient dosing and reduced side effects.
David A Degoey, David J Grampovnik, Charles A Flentge, William J Flosi, Hui-Ju Chen, David C Morfitt

J Med Chem· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Practical preclinical model for assessing the potential for unconjugated hyperbilirubinemia produced by human immunodeficiency virus protease inhibitors.
Dale J Kempf, Jeffrey F Waring, David C Morfitt, Paige Werner, Brian Ebert

Antimicrob Agents Chemother· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microvesicular steatosis induced by a short chain fatty acid: effects on mitochondrial function and correlation with gene expression.
Robert A Jolly, Rita Ciurlionis, David Morfitt, Mary Helgren, Reid Patterson

Toxicol Pathol· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interlaboratory evaluation of rat hepatic gene expression changes induced by methapyrilene.
Jeffrey F Waring, Roger G Ulrich, Nick Flint, David Morfitt, Arno Kalkuhl

Environ Health Perspect· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identifying toxic mechanisms using DNA microarrays: evidence that an experimental inhibitor of cell adhesion molecule expression signals through the aryl hydrocarbon nuclear receptor.
Jeffrey F Waring, Rebecca Gum, David Morfitt, Robert A Jolly, Rita Ciurlionis

Toxicology· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis